TEL AVIV, Israel, August 10, 2023 HAGAR, the developer of GWave, a non-invasive continuous glucose monitoring technology that uses RF (radio frequency) waves to measure glucose levels in the blood, has announced it closed a Round C funding round of $5 million, bringing its total raised to date to $25 million. Additionally, Dr. Irl Hirsch presented HAGAR’s latest data from a proprietary study conducted at the Weizmann Institute of Science on the GWave device at the 83rd Scientific Sessions of th
Diabetes self-management education expert Travis Wolff has a few ways to help you gain a better understanding of continuous glucose monitors , how to use them, and how they can grow your revenue. From training patients to apply monitors correctly to gleaning data from them to troubleshooting simple questions, Wolff has you covered. Register now for “Understanding the Role of Continuous Glucose Monitoring in Your Pharmacy” (Sep. 7), an hour-long webinar.
While costs and stigma are hurdles, these devices reduce the number of pricks, can adjust insulin for different time periods of day and night, exercise, sickness, menstruation, exams and different day to day situations. Use of insulin pumps reduces episodes of low blood glucose (hypoglycemia) and improves overall control (HbA1c), says Dr Ambrish Mithal, Chairman of Endocrinology and Diabetes, Max Healthcare